modified vitamin A (Alkeus)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemodified vitamin A (Alkeus)
Drug Alias NameC20-D3-vitamin A (Columbia)C20-D3-retinyl acetate (Alkeus)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin A agonists
TargetsUpdating
Therapy Area/IndicationsMacular DegenerationStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMacular DegenerationStargardt Disease

Other Information

ATC CodeN/A
Related LinksN/A